News

This year’s Berlin Institute of Systems Biology of the Max Delbrück Center summer meeting explored “AI’s Adventures in Genomics.” The meeting provided molecular and computational biologists a forum to discuss the latest advances, challenges, and prospects in harnessing AI for biomedical research.

Whether COVID-19 is mild or severe depends not only on how aggressive the coronavirus is, but also on the immune response of the infected individual. Using single-cell analyses, Berlin researchers have now identified two distinct molecular patterns that are typical, they write in “Cell Reports.”

The International Ph.D. Student Cancer Conference kicks off on June 12th at the Max Delbrück Center in Berlin-Buch. Doctoral students in the cancer field will get the chance to network and exchange ideas in an informal setting.

Whether it's a pub quiz, enjoying art, a lab tour or a hands-on experiment – during the Long Night of Science on June 22, visitors in Berlin-Buch and Mitte can explore biomedical research at the Max Delbrück Center from many different perspectives. A look deep into the human heart is also on offer.

At the first Helmholtz Institute for Translational AngioCardioScience (HI-TAC) conference, researchers from the Max Delbrück Center and Heidelberg University discussed bridging the gap between vascular and cardiac research, and translating research findings to clinical practice.

In a study led by Professor Jan Korbel, Senior Scientist and Head of Data Science at the European...

Preeclampsia is one of the most common pregnancy-related complications. Florian Herse of the Max Delbrück Center and Martin Gauster of the Medical University of Graz are studying the role that Hofbauer cells play in the disorder. They have been awarded a D-A-CH grant totaling €700,000 for their research.

Captain T Cell, a spin-off from the Max Delbrück Center, raised €8.5 million in startup funding. The startup focuses on developing T cells to target solid tumors. The funds are intended to move a new generation of T cell therapies towards the clinic.

Fabian Coscia combines mass spectrometry at the single-cell level, artificial intelligence, microscopy and robotics to search for the proteins in cells that are responsible for serious diseases such as cancer – and that can make them resistant to therapies. His hope: to save lives.

On May 14, the Helmholtz Imaging announced the winners of their 2024 annual scientific imaging contest – six Max Delbrück Center researchers were among them.